<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154744">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01085435</url>
  </required_header>
  <id_info>
    <org_study_id>DN-15627; DN 15677</org_study_id>
    <nct_id>NCT01085435</nct_id>
  </id_info>
  <brief_title>Boston Scientific Post Market S-ICD Registry</brief_title>
  <acronym>EFFORTLESS</acronym>
  <official_title>Evaluation oF Factors ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD (The EFFORTLESS S-ICD Registry)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The EFFORTLESS ICD Registry is an observational, standard of care evaluation designed to
      demonstrate the early, mid and long-term clinical effectiveness the Cameron Health S-ICD
      System. In addition, analysis of resource utilization and costs will be performed to
      document treatment costs for periods defined by Registry endpoints. Protocol DN 15627 (Aug
      06, 2010) restricts enrolment to patients over 18 years of age while protocol amendment DN
      15677 (Aug 30, 2010) allows all patients to be included. Countries can chose their route for
      approval
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      EFFORTLESS is an observational, post market, standard of care, Registry to be conducted at
      approximately 50 centers worldwide in patients requiring an ICD for the treatment of
      ventricular tachyarrhythmias. Patients included in the registry will have been implanted
      with the S-ICD system since its CE mark(commercial regulatory approval) and will be followed
      for up to 60 months. The patients' perception of their therapy will be evaluated using
      Quality of Life assessments and the Registry will include an exploratory analysis of
      resource utilization and costs based on measures of clinical outcome such as complication
      rates, unscheduled hospitalizations and length of stay. The objective will be to enable
      comparison of costs of the S-ICD system versus a standard transvenous system.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Actual">November 24, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Perioperative S-ICD Complication Free Rate</measure>
    <time_frame>30 days post implant</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>360 Day S-ICD Complication Free Rate</measure>
    <time_frame>Minimum 360 days post implant</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of inappropriate shocks for AF/SVT</measure>
    <time_frame>Study duration</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Tachycardia, Ventricular</condition>
  <arm_group>
    <arm_group_label>S-ICD System Commercial Patients</arm_group_label>
    <description>Patients implanted with a CE marked S-ICD System, not participating in Cameron Health's Investigational Device Exemption (IDE) Clinical Study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>S-ICD System</intervention_name>
    <description>The S-ICD System is an implantable technology that uses a subcutaneous pulse generator and subcutaneous electrode system to treat ventricular tachyarrhythmias. The S-ICD System consists of the SQ-RX pulse generator (Model 1010), the Q-TRAK subcutaneous electrode (Model 3010), the Q-TECH programmer (Model 2020), and Q-GUIDE electrode insertion tools (Models 4010 and 4020).</description>
    <arm_group_label>S-ICD System Commercial Patients</arm_group_label>
    <other_name>SQ-RX Pulse Generator</other_name>
    <other_name>Q-TRAK Subcutaneous Electrode</other_name>
    <other_name>Q-GUIDE Electrode Insertion Tools</other_name>
    <other_name>Q-TECH Programmer</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Post CE mark ICD patients eligible for implantation of the S-ICD system
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Age &gt;/= 18yrs

          2. Eligible for implantation of an S-ICD system per local clinical guidelines or
             currently implanted with an S-ICD system (SW version 1.59.0 or later)

          3. Willing and able to provide written informed consent or have informed consent as
             provided by a legal representative

        Exclusion Criteria:

          1. 1. Participation in any other investigational study that may interfere with
             interpretation of the Registry results

          2. Incessant ventricular tachycardia and/or spontaneous, frequently recurring
             ventricular tachycardia that is reliably terminated with anti-tachycardia pacing

          3. Patients with unipolar pacemakers or implanted devices that revert to unipolar pacing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pier Lambiase, PhD FRCP</last_name>
    <role>Study Chair</role>
    <affiliation>The Heart Hospital, London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Na Homolce Hospital</name>
      <address>
        <city>Prague</city>
        <state>Prague 5</state>
        <zip>15030</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>København Ø</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <state>Odense C</state>
        <zip>DK-5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Bernau</name>
      <address>
        <city>Bernau</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg</name>
      <address>
        <city>Coburg</city>
        <zip>96450 Coburg</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Munich Groβhadern</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>AZ Maastricht</state>
        <zip>6202</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina Eindhoven Hospital</name>
      <address>
        <city>Eindhoven</city>
        <state>EJ Eindhoven</state>
        <zip>5623</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amsterdam Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Spectrum Twente</name>
      <address>
        <city>Enschede</city>
        <zip>7513 ER</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9713</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3430 EM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3000 CA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Auckland</city>
        <zip>1142</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Papworth Hospital</name>
      <address>
        <city>Cambridge</city>
        <state>Cambridgeshire</state>
        <zip>CB23 3RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <state>Yorkshire</state>
        <zip>LS1 1YY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Sussex County Hospital</name>
      <address>
        <city>Brighton</city>
        <zip>BN2 5BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bristol Royal Infirmary</name>
      <address>
        <city>Bristol</city>
        <zip>BS2 8HW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Russells Hall Hospital</name>
      <address>
        <city>Dudley</city>
        <zip>DY1 2HQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yorkhill Children's Hospital</name>
      <address>
        <city>Glasgow</city>
        <zip>G3 8SJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital</name>
      <address>
        <city>London</city>
        <zip>W1G 8SE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>March 23, 2017</lastchanged_date>
  <firstreceived_date>March 10, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICD</keyword>
  <keyword>defibrillator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
